AU2021105959A4 - Nappy Cream - Google Patents
Nappy Cream Download PDFInfo
- Publication number
- AU2021105959A4 AU2021105959A4 AU2021105959A AU2021105959A AU2021105959A4 AU 2021105959 A4 AU2021105959 A4 AU 2021105959A4 AU 2021105959 A AU2021105959 A AU 2021105959A AU 2021105959 A AU2021105959 A AU 2021105959A AU 2021105959 A4 AU2021105959 A4 AU 2021105959A4
- Authority
- AU
- Australia
- Prior art keywords
- formulation
- weight
- skin
- microcare
- cas number
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
Abstract
A nappy cream formulation includes the following active ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation;
• Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation;
• Calendula C02, comprising 0.1% to 1% by weight of the formulation; and
• Betaine, comprising 1% to 5% by weight of the formulation.
Description
This invention relates to a nappy cream. It relates particularly but not exclusively to a
protective nappy cream which creates a protective barrier against irritants and can be used to treat minor skin ailments such as burns, cuts, minor wounds, dandruff and eczema.
A nappy cream is a topical product used to place a physical barrier between the skin and
contaminants that may irritate the skin. Although the most obvious use of a nappy cream is in treating nappy rash, nappy cream is also useful for athletes who suffer from chafing,
people who suffer from bedsores, and people who are suffering dry or irritated skin.
Many nappy creams use dimethicone as a key ingredient. Dimethicone is silicon-based and
gives the cream a smooth, silky texture. However, it is often said thatdimethicone exacerbates acne by forming a barrier over skin, which traps not just moisture, but also
bacteria, skin oils, sebum, and other impurities.
According to the present invention there is provided a nappy cream formulation including the following active ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation; • Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation; and
• Calendula C02, comprising 0.1% to 1% by weight of the formulation
• Betaine, comprising 1% to 5% by weight of the formulation
The nappy cream formulation may include any suitable thickeners, emulsifiers, preservatives, humectants, colourants, fragrances, antioxidants and pH adjusters. Suitable
additional ingredients which fulfil these functions are:
• Xanthan Gum, comprising 0.1% to 1% by weight of the formulation;
• Glycerine, comprising 1% to 5% by weight of the formulation;
• Cetyl Alcohol, comprising 1% to 5% by weight of the formulation;
• Cetyl Stearyl Alcohol, comprising 0.5% to 5% by weight of the formulation;
• Caprylic/Capric Triglyceride, comprising 5% to 10% by weight of the formulation;
• Benzyl Alcohol, comprising 0.1% to 1% by weight of the formulation;
Microcare DB, compromising of 0.1% to 1% by weight of the formulation
• Microcare SB, compromising of0.1% to 1% by weight of the formulation
• Polawax NF, comprising 1% to 5% by weight of the formulation;
• SEOC Relax Me Blend, comprising 0.1% to 5% by weight of the formulation; and
• Lactic Acid, comprising 0.05% to 1% by weight of the formulation.
A method of manufacturing a nappy cream formulation according to the invention includes the following steps:
a) Combine the purified water including Aloe Barbadensis Leaf Powder with the
glycerine and heat to 65-70°C. Sift in the Xanthan gum and mix under high shear
until fully hydrated. b) Combine the Cetyl Alcohol, Cetyl Stearyl Alcohol, Caprylic/Capric Triglyceride, Benzyl
Alcohol, Shea Butter, Jojoba Oil, Microcare DB, Microcare SB, and Polawax NF, and heat to 70°C.
c) Combine the Green Tea Extract, Kakadu Plum Extract, SEOC Relax Me Blend,
Calendula C02 and Betaine. d) Add the mixture of step (b) to the mixture of step (a) and emulsify. Stir while cooling.
e) When cooled below 30°C, add the mixture of step (c). Stir until mixed thoroughly. f) Add the Lactic Acid and continue stirring until mixed thoroughly. g) Check and adjust the pH to the final required setting 6.0-6.5.
The invention will now be described in more detail with reference to a particular embodiment. It is to be understood that the specific details of the embodiment do not
supersede the generality of the foregoing description.
The example embodiment of a nappy cream formulation according to the present invention
includes the following ingredients:
Phase A ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation;
• Xanthan Gum, comprising 0.1% to 1% by weight of the formulation; and
• Glycerine, comprising 1% to 5% by weight of the formulation.
Phase B ingredients:
• Cetyl Alcohol, comprising 1% to 5% by weight of the formulation;
• Cetyl Stearyl Alcohol, comprising 0.5% to 5% by weight of the formulation;
• Caprylic/Capric Triglyceride, comprising 5% to 10% by weight of the formulation;
• Benzyl Alcohol, comprising 0.1% to 1% by weight of the formulation;
• Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
6 Microcare DB, compromising of 0.1% to 1% by weight of the formulation;
Microcare SB, compromising of0.1% to 1% by weight of the formulation; and
• Polawax NF, comprising 1% to 5% by weight of the formulation.
Phase C ingredients:
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation;
• SEOC Relax Me Blend, comprising 0.1% to 5% by weight of the formulation;
• Calendula C02, comprising 0.1% to 1% by weight of the formulation; and
• Betaine, comprising 1% to 5% by weight of the formulation;
Phase D ingredient:
• Lactic Acid, comprising 0.05% to 1% by weight of the formulation.
The formulation is created by the following steps:
1. Combine the purified water including Aloe Barbadensis Leaf Powder with the glycerine and heat to 65-70°C. Sift in Xanthan gum and mix under high shear until
fully hydrated. 2. Combine ingredients in Phase B and heat to 70°C.
3. Add phase B to Phase A and emulsify. Stir while cooling.
4. When cooled below 30°C, add pre-combined ingredients from phase C. Stir until mixed thoroughly.
5. Add phase D ingredient and continue stirring until mixed thoroughly. 6. Check and adjust the pH to the final required setting 6.0-6.5.
This results in a viscous liquid, with a density of approximately 1.
The pH of cosmetic products should remain in a certain range so that the colour, viscosity, skin feel, and physicochemical stability remains intact during its shelf-life and during its
application by the consumer.
The pH scale ranges from 0 to 14, where a pH of 7 is neutral, while a pH less than 7 is acidic
and a pH greater than 7 is basic or alkaline. The skin's normal pH is slightly acidic.
If the skin pH is too acidic (less than 5.5) it can become irritated, red, inflamed, and even
painful to touch. If the skin pH is too alkaline (greater than 5.5), it can become dry,
sensitive, and the person may even develop eczema. Newborns have relatively high pH levels all over the skin. As babies get older, their pH levels decline. The average newborn has
a skin pH of about 7. This is compared to the average adult skin pH of 5.7.
It is therefore advisable when formulating washes, lotions, and creams to reach a pH between 5-7 and the general rule is that slightly acidic products are preferred and perform
better for children.
Once the formulation process has been completed it is time to measure the pH of the product, where one of these 3 possibilities can occur:
1. The pH of the product is exactly in the desired range and in the range where the
preservative system has the highest efficiency. This is unfortunately rare, and in most cases, it will be necessary either to reduce or increase the pH, dependent on the product being
formulated.
2. If the pH of the product is higher than the desired range, it needs to be reduced. Citric acid, and lactic acid are the most suitable acids to reduce the pH of a cosmetic
product.
3. If the product pH is lower than the desired range it can be increased with Sodium Citrate.
The particular ingredients and the reasons for their selection will now be described in
further detail.
Purified Water: Purified water (CAS number 7732-18-5) is combined with about 0.5% by
weight of Aloe Barbadensis Leaf Powder (CAS number 85507-69-3 / 94349-62-9). As a
cosmetic ingredient, aloe vera is widely used in many mainstream skincare and cosmetics products. The plant is skin-friendly and has a low risk of causing allergies, sensitivity or skin
reactions, and it is also versatile. It also aids protection of the epidermis and the skin's ability to restore itself and commonly used in after-sun products, facial, hair and body care. From the juice of Aloe Vera leaves this ingredient adds a calming effect to the skin. It is
known for soothing irritation and itching as well as being lightly moisturising.
Xanthan Gum (CAS number 11138-66-2): This is used in a variety of cosmetics and personal care products to help improve binding, emulsification, and thickening of the product.
Naturally plant derived and safe to use in skincare, the most effective way to disperse this gum is to blend into Glycerin to make a paste that can easily be mixed into the formulation.
Glycerine (Glycerin CAS number 56-81-5): This is used to provide smoothness and
lubrication. It is also a well-known humectant that prevents the loss of moisture from products so they don't dry out as quickly.
Cetyl Alcohol (CAS number 36653-82-4): This helps to create smoother creams, thicker lotions, and more stable foam products. It is used to soften the skin/hair as an emollient. It
is considered an effective ingredient for soothing and healing dry skin.
CSA (Cetyl Stearyl Alcohol) (CAS number 67762-27-0 / 8005-44-5): This is an emulsifier which helps prevent creams from separating into oil and liquid. As an emollient, cetyl
alcohol has the ability to soften and smooth flakiness on the skin, which helps to reduce rough, dry skin.
GTCC (Caprylic/Capric Triglyceride) (CAS number 73398-61-5): Fractionated coconut oil of
Caprylic/Capric Triglyceride is a light colourless carrier oil which will not stain clothing, is odorless and has a long shelf life and stability, acting as an emollient, lubricant and solvent.
Butyrospermum Parkii (Shea) Butter (CAS number 194043-92-0): This has good emolliency
and moisturising properties and is a skin conditioning and viscosity increasing agent.
Simmondsia Chinensis (Jojoba) Seed Oil (CAS number 90045-98-0): This is a carrier oil that acts as a moisturizer and emollient, prevents transdermal water loss and retains moisture. It
has good lubricant properties without leaving a greasy film on the skin as it penetrates.
Microcare DB: This is composed of approximately 87% Benzyl Alcohol (CAS number 100-51 6) and 13% Dehydroacetic Acid (CAS number 520-45-6). It is a preservative effective against
a broad range of bacteria, moulds and yeasts. It meets Ecocert and COSMOS standards, and is NaTrue Certified and Soil Association approved.
Microcare SB: This is composed of approximately 55% purified water (CAS number 7732-18 ), 30% Sodium Benzoate (CAS number 532-32-1), and 15% Potassium Sorbate (CAS number
24634-61-5). It is a preservative, effective against a broad range of bacteria, moulds and yeasts and is ideal for Ecocert applications.
As a paraben and formaldehyde-free preservative system, the combination of Microcare DB
and Microcare SB ingredients provides optimized protection against microbial growth from both bacteria and yeast while imparting a pleasant feel to the finished product. There are no
pH restrictions and it is compatible with most raw materials.
Polawax NF: This is composed of approximately 75% Cetearyl Alcohol (CAS number 67762 27-0 / 8005-44-5) and 25% Polysorbate 60 (CAS number 9005-67-8): It is a vegetable-derived emulsifying wax and stabiliser used in lotions and creams to give them a smooth consistency and help keep them from separating.
Kakadu Plum Extract: This is composed of approximately 19% purified water (CAS number
7732-18-5), 70% Glycerin (CAS number 56-81-5), 10% Terminalia Ferdinandiana Fruit Extract (CAS number 1176234-54-0), and 1% Sodium Benzoate (CAS number 532-32-1). This
includes a number of essential nutrients including Vitamin C, and has antiseptic wound healing properties whilst soothing for hypersensitive skin. It is good for stretch marks,
antioxidant, anti-inflammatory and antimicrobial properties, reduces redness, swelling and skin irritation.
Green Tea Extract: This is composed of approximately 50% Glycerin (CAS number 56-81-5),
33% purified water (CAS number 7732-18-5), 15% Camellia Sinensis Leaf Extract (CAS number 84650-60-2), and 2% Potassium Sorbate (CAS number 24634-61-5). This extract is
an effective antioxidant and UV protectant, and is anti-inflammatory, anticarcinogenic and antimicrobial. It helps to speed up skin exfoliation and aids in skin hydration.
SEOC Relax Me Blend: This is composed of approximately 35% Citrus Nobilis (Mandarin Orange Peel) Oil (CAS number 8008-31-9), 25% Cedrus Atlantica Bark (Cedarwood) Oil (CAS
number 8000-27-9), 20% Lavandula Angustifolia (Lavender) Oil (CAS number 8000-28-0), % Lavandula Hybrida Oil (CAS number 8022-15-9), 5% Citrus Aurantium Bergamia
(Bergamot) Fruit Oil (CAS number 8007-75-8) and 5% Anthemis Nobilis Flower (Roman chamomile) Oil (CAS number 84649-86-5). Citrus Nobilis (Mandarin Orange Peel) Oil has significant antioxidant properties. It is mild and calming, anti-inflammatory, and has
antimicrobial and refreshing properties. Cedrus Atlantica Bark (Cedarwood) Oil is anti inflammatory, antiseptic, and beneficial for muscular aches. It is a scalp tonic suitable for
oily skin and hair treatment such as dandruff and cradle cap. Lavandula Angustifolia (Lavender) Oil has antiseptic and anti-inflammatory properties and is effective in treating
acne, dermatitis and oily skin. It promotes rapid healing and helps reduce scarring. Lavandula Hybrida Oil is used as a fragrance ingredient in cosmetics. Its sensitiser potential
for skin is similar to that of lavender oil and camphor. Citrus Aurantium Bergamia
(Bergamot) Fruit Oil has antibacterial, deodorising, refreshing, soothing, and uplifting properties which make it suitable for body skincare preparations. Anthemis Nobilis Flower
(Roman chamomile) Oil is used to help calm inflamed skin and ease skin conditions like eczema or rashes.
Calendula C02 (CAS number 84776-23-8): This has good skincare properties. It promotes
wound healing, reduces inflammation, relieves dry and itchy skin and is ideal for the treatment of eczema, nappy rash, sunburn, and sensitive skin.
Betaine (CAS number 107-43-7): Naturally derived from sugar beet (Beta vulgaris), this
works by providing astringent, antiseptic and skin regenerating properties. Betaine has demonstrated anti-inflammatory properties against erythema (a name given to any
abnormal redness of the skin), and can help with irritating symptoms such as itching, redness, peeling skin and inflammation. Given that betaine is naturally occurring in the
body, it is non-irritating and a sage ingredient to help improve the condition of the skin.
Lactic Acid (CAS number 124-68-5), approximately 88% combined with purified water (CAS number 7732-18-5), approximately 12%: Often used as a natural pH adjuster in
formulations, lactic acid is produced by the fermentation of carbohydrates. Lactic acid protects the skin against external influences like bacteria, allergens and pollution, while maintaining moisture.
A nappy cream formulation of the type provided by the present invention is designed to create a protective barrier against everyday irritants, as well as to treat redness and soothe
and nourish delicate skin. Known as a topical protectant Calendula C02 extract and Betaine work-by providing astringent, antiseptic and skin regenerating properties. It is used to treat
minor skin ailments such as burns, cuts, minor wounds, dandruff and eczema and can help
with irritating symptoms such as itching, redness, peeling skin and inflammation, all of which are symptoms used to describe nappy rash.
Claims (3)
1. A nappy cream formulation including the following active ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation;
• Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation;
• Calendula C02, comprising 0.1% to 1% by weight of the formulation; and
• Betaine, comprising 1% to 5% by weight of the formulation.
2. A nappy cream formulation according to claim 1 including the following additional ingredients:
• Xanthan Gum, comprising 0.1% to 1% by weight of the formulation;
• Glycerine, comprising 1% to 5% by weight of the formulation;
• Cetyl Alcohol, comprising 1% to 5% by weight of the formulation;
• Cetyl Stearyl Alcohol, comprising 0.5% to 5% by weight of the formulation;
• Caprylic/Capric Triglyceride, comprising 5% to 10% by weight of the formulation;
• Benzyl Alcohol, comprising 0.1% to 1% by weight of the formulation;
6 Microcare DB, compromising of 0.1% to 1% by weight of the formulation;
Microcare SB, compromising of 0.1% to 1% by weight of the formulation;
• Polawax NF, comprising 1% to 5% by weight of the formulation;
• SEOC Relax Me Blend, comprising 0.1% to 5% by weight of the formulation; and
• Lactic Acid, comprising 0.05% to 1% by weight of the formulation.
3. A method of manufacturing a nappy cream formulation according to claim 2 including the following steps: a) Combine the purified water including Aloe Barbadensis Leaf Powder with the glycerine and heat to 65-70°C. Sift in the Xanthan gum and mix under high shear until fully hydrated. b) Combine the Cetyl Alcohol, Cetyl Stearyl Alcohol, Caprylic/Capric Triglyceride, Benzyl
Alcohol, Shea Butter, Jojoba Oil, Microcare DB, Microcare SB and Polawax NF, and heat to 70°C.
c) Combine the Green Tea Extract, Kakadu Plum Extract, SEOC Relax Me Blend, Calendula C02, and Betaine.
d) Add the mixture of step (b) to the mixture of step (a) and emulsify. Stir while cooling.
e) When cooled below 30°C, add the mixture of step (c). Stir until mixed thoroughly. f) Add the Lactic Acid and continue stirring until mixed thoroughly.
g) Check and adjust the pH to the final required setting 6.0-6.5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021105959A AU2021105959A4 (en) | 2021-08-19 | 2021-08-19 | Nappy Cream |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021105959A AU2021105959A4 (en) | 2021-08-19 | 2021-08-19 | Nappy Cream |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021105959A4 true AU2021105959A4 (en) | 2021-10-28 |
Family
ID=78179603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021105959A Active AU2021105959A4 (en) | 2021-08-19 | 2021-08-19 | Nappy Cream |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021105959A4 (en) |
-
2021
- 2021-08-19 AU AU2021105959A patent/AU2021105959A4/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11571373B2 (en) | Skin care preparations for babies | |
KR102257342B1 (en) | Composition for antimicrobial and anti-inflammatory activities and manufacturing method thereof | |
KR101987903B1 (en) | Cosmetic composition for treating atopic dermatitis and method thereof | |
CN106361599A (en) | Multi-vegetable-oil-containing infantile eczema care cream | |
JPH08505630A (en) | Pharmaceutical and skin cosmetic compositions containing equine colostrum | |
CN113197836A (en) | Moisturizing, relieving, itching-relieving and skin-protecting cream and preparation method thereof | |
US20150374613A1 (en) | Hair loss prevention and restoration solution | |
CN110638727B (en) | Infant hip-protecting composition and preparation method and application thereof | |
KR20090041886A (en) | Botanical triple hydro complex and skin care formulation comprising the same | |
CN112472653A (en) | Acne-removing aloe gel and preparation method thereof | |
WO2022222215A1 (en) | Skin care composite essence oil | |
US10111827B2 (en) | Hair loss prevention and restoration solution | |
US20040234628A1 (en) | Topical composition for the treatment of skin disorders and methods of using the same | |
US20190160134A1 (en) | Formulations for Cosmetic and Dermatological Applications | |
US20200030398A1 (en) | Skin care composition | |
AU2021105959A4 (en) | Nappy Cream | |
CN111228154A (en) | Fresh wheat extract protoplasm milk for infants and preparation method thereof | |
AU2021105956A4 (en) | Nappy Cream | |
CN108938514B (en) | Skin-clearing acne-removing liquid and preparation method thereof | |
KR102217697B1 (en) | Aromatherapy composition comprising natural aroma oil | |
AU2021105957A4 (en) | Body Lotion | |
AU7733401A (en) | Method for promoting clear skin | |
RU2205627C1 (en) | Toxin-removal face cream | |
AU2021105954A4 (en) | Multi-purpose mineral bodywash | |
AU2021105955A4 (en) | Hair and body wash |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) |